Cargando…
Inherited Thrombocytopenia Caused by Germline ANKRD26 Mutation Should Be Considered in Young Patients With Suspected Myelodysplastic Syndrome
Thrombocytopenia 2 (THC2) is an autosomal dominant disorder characterized by ankyrin repeat domain 26 mutation and moderate thrombocytopenia. THC2 exposes patients to a low risk of bleeding and an increased likelihood of myelodysplastic syndrome/acute myeloid leukemia. Germline evaluation for a gene...
Autores principales: | Kewan, Tariq, Noss, Ryan, Godley, Lucy A., Rogers, Heesun J., Carraway, Hetty E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493274/ https://www.ncbi.nlm.nih.gov/pubmed/32618208 http://dx.doi.org/10.1177/2324709620938941 |
Ejemplares similares
-
Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations
por: Drazer, Michael W., et al.
Publicado: (2022) -
ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26
por: Perez Botero, J, et al.
Publicado: (2015) -
Idiopathic Pulmonary Embolism in a case of Severe Family ANKRD26 Thrombocytopenia
por: Guison, Jerome, et al.
Publicado: (2017) -
Emerging treatment options for patients with high-risk
myelodysplastic syndrome
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2020) -
Familial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript
por: Wahlster, Lara, et al.
Publicado: (2021)